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Abstract
 
Capacitative Ca
 
2
 
 
 
 entry (CCE) activated by release/depletion of Ca
 
2
 
 
 
 from internal stores rep-
resents a major Ca
 
2
 
 
 
 influx mechanism in lymphocytes and other nonexcitable cells. Despite
the importance of CCE in antigen-mediated lymphocyte activation, molecular components
constituting this mechanism remain elusive. Here we demonstrate that genetic disruption of
transient receptor potential (TRP)1 significantly attenuates both Ca
 
2
 
 
 
 release-activated Ca
 
2
 
 
 
currents and inositol 1,4,5-trisphosphate (IP
 
3
 
)-mediated Ca
 
2
 
 
 
 release from endoplasmic reticu-
lum (ER) in DT40 B cells. As a consequence, B cell antigen receptor–mediated Ca
 
2
 
 
 
 oscilla-
tions and NF-AT activation are reduced in TRP1-deficient cells. Thus, our results suggest that
CCE channels, whose formation involves TRP1 as an important component, modulate IP
 
3
 
 re-
ceptor function, thereby enhancing functional coupling between the ER and plasma mem-
brane in transduction of intracellular Ca
 
2
 
 
 
 signaling in B lymphocytes.
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Introduction
 
In many cells, receptor activation evokes an increase in cy-
tosolic Ca
 
2
 
 
 
 concentration [Ca
 
2
 
 
 
]
 
i
 
 which is critical for ini-
tiating cellular responses (1–5). This increase is comprised
of an initial phase that reflects Ca
 
2
 
 
 
 release from intracellu-
lar stores and a second phase that is due to Ca
 
2
 
 
 
 influx
through Ca
 
2
 
 
 
 permeable ion channels in the plasma mem-
brane. The magnitude of the change in [Ca
 
2
 
 
 
]
 
i
 
 relies on
the activation of Ca
 
2
 
 
 
 entry through plasma-membrane
channels induced by depletion of Ca
 
2
 
 
 
 from internal stores
such as endoplasmic reticulum (ER)
 
*
 
 via inositol 1,4,5-tris-
phosphate (IP
 
3
 
) as well as other regulatory mechanisms, in-
cluding modulation of Ca
 
2
 
 
 
 uptake and sequestration,
changes in membrane potential, and/or other as yet un-
known mechanisms downstream of receptor activation.
Ca
 
2
 
 
 
 entry due to store depletion is often called capacita-
tive Ca
 
2
 
 
 
 entry (CCE) and is mediated by Ca
 
2
 
 
 
-permeable
 
✪
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Ca
 
2
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2
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2
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3
 
, inositol 1,4,5-trisphosphate; IP
 
3
 
R, IP
 
3
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phospholipase C; SOC, store-operated Ca
 
2
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674
 
Control of BCR-induced Ca
 
2
 
 
 
 Signal by TRP1
 
channels termed store-operated Ca
 
2
 
 
 
 channels (SOCs). The
best-studied SOCs in terms of biophysical properties are
Ca
 
2
 
 
 
-release-activated Ca
 
2
 
 
 
 (CRAC) channels, originally
described in mast cells and characterized by their inwardly
rectifying current-voltage relationship as well as by their
high selectivity for Ca
 
2
 
 
 
 (6, 7). Other less Ca
 
2
 
 
 
-selective
SOCs have been also described in many tissues (8–12).
Hence, the molecular identities of SOCs are still controver-
sial and are probably not identical in the various cell types.
In lymphocytes, the importance of CCE in maintaining
normal T cell function has been underscored by analysis of
immunodeficiency patients, whose T cells failed to show ac-
tivation of a sustained Ca
 
2
 
 
 
 influx upon TCR stimulation,
despite the successful release of Ca
 
2
 
 
 
 from the ER stores
(13–15). This defective CCE causes an insufficient T cell ac-
tivation in the patient presumably through impairment of
NF-AT activation, since CCE is required to maintain NF-
AT activation in antigen-stimulated T cells (16, 17). Also, in
B lymphocytes, the two phases of Ca
 
2
 
 
 
 mobilization are
known to be differentially coupled to signaling pathways (4).
While the small transient Ca
 
2
 
 
 
 spike mediated by release
from the ER stores is sufficient to activate transcriptional
regulators such as NF-
 
 
 
B and c-Jun NH
 
2
 
-terminal kinase, it
is insufficient for activation of NF-AT. Instead, NF-AT acti-
vation, like in T cells, requires CCE and a sustained increase
in [Ca
 
2
 
 
 
]
 
i
 
. Collectively, these studies clearly demonstrate the
importance of CCE in lymphocyte activation; however, the
molecular natures of SOCs in lymphocytes are still unclear.
To address the mechanisms by which CCE is activated
upon B cell receptor (BCR) engagement, we first sought
to determine the molecular components of SOCs in B
cells. The seven mammalian homologs of 
 
Drosophila tran-
sient receptor potential 
 
(
 
trp)
 
 proteins, have emerged as candi-
date subunits of the SOCs in B cells, based on the follow-
ing evidence. First, several members of TRP families,
including TRP1, are indeed expressed in the spleen and B
cells (18–20; see Fig. 1). Second, once overexpressed in
CHO and COS cells, TRP1 has been demonstrated to
produce Ca
 
2
 
 
 
-permeable cation currents that were acti-
vated after depletion of internal Ca
 
2
 
 
 
 stores (21–23), while
some papers proposed TRP1 as a component of receptor-
mediated nonselective cation channels activated indepen-
dently of depletion of stores (24, 25). These findings
prompted us to examine whether TRP1 functions indeed
as SOCs in the BCR signaling context. In this paper, we
demonstrate by genetically disrupting TRP1 that this mol-
ecule is critical for forming functional SOCs, thereby con-
tributing to generation of regular Ca
 
2
 
 
 
 oscillations and sub-
sequent NF-AT activation. Our results also implicate
important involvement of TRP1 in coordination of ele-
mentary Ca
 
2
 
 
 
 signaling events that promote functional
coupling between the ER and plasma membrane in trans-
duction of BCR-induced Ca
 
2
 
 
 
 signaling.
 
Materials and Methods
 
Generation of TRP1-deficient DT40 Cells.
 
The chicken ge-
nomic TRP1 DNA was obtained by PCR using a pair of primers
 
chT1–31 (sense, 5
 
 
 
-AGACTGTGGTATGAAGGGTTGGAA-
GACTTC-3
 
 
 
) and chT1–1 (antisense, 5
 
 
 
-TCGGGCGAATTT-
CCATTCCTTATCTTC-3
 
 
 
). The targeting vector of TRP1
was constructed by replacing the genomic sequence, which en-
codes the fifth hydrophobic segment H5 (PTLVAEGLFAFANV-
LSYLRLFFMY) of chicken TRP1, with a histidinol (
 
hisD
 
) or
neomycin resistance gene (
 
neo
 
) cassette (26). The upstream 2.1-kb
and downstream 5.2-kb genomic sequences were generated by
PCR using the TRP1 genomic clone as a template. DT40 cells
were cultured in RPMI 1640 supplemented with 10% FCS, 1%
chicken serum, penicillin, streptomycin, and glutamine. The tar-
geting vector was linearized and transfected sequentially into
DT40 cells by electroporation (550 V, 25 
 
 
 
F). After isolation of
several clones in the presence of 1 mg/ml histidinol or 2 mg/ml
G418, genomic DNAs were prepared and analyzed by Southern
blot analysis using the 3
 
 
 
-flanking probe. In a PCR experiment to
confirm that the TRP1-deficient preparation is free from con-
tamination of wild-type (WT) cells, a pair of primers K2723
(sense, 5
 
 
 
-TAGAAGAGTCACGCAATCAGCTTAGTT-3
 
 
 
) and
K2725 (antisense, 5
 
 
 
-CGCAGATAACTCAGCACATTAGCA-
AATGC-3
 
 
 
) were used: K2723 and K2725 anneal with the re-
spective sequences in the neighboring exons, of which the K2725
primer-annealing sequence in the 3
 
 
 
 exon is eliminated by dis-
ruption with the 
 
hisD
 
 or 
 
neo
 
 cassette in TRP1-deficient cells. Cell
surface expression of BCR was analyzed by FACScan™ (Becton
Dickinson) using FITC-labeled anti–chicken IgM. The two tar-
geted mutant clones, TRP1
 
 
 
-14 and TRP1
 
 
 
-16, were analyzed
extensively, although reproducibility of the results was confirmed
using additional clones.
 
Northern Blot Analysis.
 
Isolation of total RNA and hybridiza-
tion was performed as described previously (20). Probe used was
the chicken TRP1 cDNA isolated by RT-PCR amplification
from the DT40 poly(A)
 
 
 
 RNA using a pair of primers chT1–25
(sense, 5
 
 
 
-TGGATTATTGGGATGATTTGGTCAGAC-3
 
 
 
)
and chT1–1 (antisense) mentioned above.
 
Immunolocalization of TRP1 Proteins.
 
DT40 cells on coverslips
were fixed with 4% paraformaldehyde, permeabilized with 0.2%
Triton X-100, and incubated with anti-TRP1 polyclonal anti-
body (Alamone Labs, Ltd.) at 1:600 dilution, according to manu-
facturer’s instruction. Secondary antibody was the FITC-conju-
gated donkey anti–rabbit IgG antisera. The fluorescence images
were acquired with a confocal laser scanning microscope
(LSM510; Carl Zeiss Co., Ltd.) using 505-nm long path filter for
emission and an argon ion laser for excitation (488 nm).
 
Western Blot Analysis.
 
 
 
5 
 
 
 
 10
 
6
 
 cells were lysed by 100 
 
 
 
l
phosphate-buffered saline containing 1% NP-40. After centrifuga-
tion at 15,000 rpm for 10 min, 5 
 
 
 
l of supernatant was subjected
to 5% SDS-PAGE and electrotransferred onto a nitrocellulose
membrane. After blocking in 5% BSA, the membrane was incu-
bated with anti-IP
 
3 
 
receptor (IP
 
3
 
R) polyclonal antibodies (27) and
subsequently with horseradish peroxidase–conjugated anti–rabbit
IgG antibody. The bands (
 
 
 
208 kD) were visualized by enhanced
chemiluminescence method (Amersham Pharmacia Biotech).
 
cDNA Expression.
 
Human TRP1 (hTRP1) cDNA was
cloned according to Zhu et al. (18) by RT-PCR from the human
brain poly(A)
 
 
 
 RNA using pair of primers hTRP1–1 (5
 
 
 
-
CATGGGCCGCGATGATGGCGGCCCTGTACC-3
 
 
 
) and
hTRP1–2 (5
 
 
 
-GAAAATGGTTAATTTCTTGGATAAAACA-
TAGC-3
 
 
 
). To introduce the pMX
 
 
 
-IRES-GFP plasmid (28)
containing the hTRP1 cDNA to TRP1-deficient cells, vesicular
somatitis virus glycoprotein pseudotyped retrovirus was used.
 
Measurement of Changes in [Ca
 
2
 
 
 
]
 
i
 
.
 
Cells were plated onto
poly-
 
L
 
-lysine-coated glass coverslips, and were subjected to mea- 
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surements 3–6 h after plating on the coverslips. Cells on cover-
slips were loaded with 1 
 
 
 
M Fura-2/AM (Dojindo Laboratories)
at 37
 
 
 
C for 40 min, in a physiological salt solution containing (in
mM): 150 NaCl; 4 KCl; 2 CaCl
 
2
 
; 1 MgCl
 
2
 
; 5 Hepes; and 5.6
glucose, adjusted to pH 7.4 with NaOH. The coverslips were
then placed in a perfusion chamber mounted on the stage of the
microscope. Fluorescence images of the cells were recorded and
analyzed with a video image analysis system (ARGUS-20/CA;
Hamamatsu Photonics). The Fura-2 fluorescence at an emission
wavelength of 510 nm (bandwidth, 20 nm) was observed at
room temperature by exciting Fura-2 alternately at 340 and 380
nm (bandwidth, 11 nm). The 340/380 nm ratio images were ob-
tained on a pixel by pixel basis, and were converted to Ca
 
2
 
 
 
concentrations by in vitro calibration. All the reagents dissolved
in water, ethanol, or dimethylsulfoxide were diluted to their fi-
nal concentrations in the physiological salt solution and applied
to the cells by perfusion. Ca
 
2
 
 
 
-free solution contains 0.5 mM
EGTA but no added CaCl
 
2
 
. 30 mM K
 
 
 
-containing ‘high K
 
 
 
’
solution and 8 mM K
 
 
 
-containing solution were made by the
substitution of equimolar K
 
 
 
 for Na
 
 
 
. In measuring [Ca
 
2
 
 
 
]
 
i
 
 re-
sponses under fix membrane potential, 2 
 
 
 
M valinomycin was
added to the 8 mM K
 
 
 
-containing solution. Data were accumu-
lated from three to five experiments under each experimental
condition.
 
IP
 
3
 
 Generation Assay.
 
Cells (2 
 
 
 
 10
 
6
 
) were stimulated with
mAB M4 (10 
 
 
 
g) at 37
 
 
 
C for indicated time. Kinetic analysis of
IP
 
3
 
 production was performed using BIOTRAK IP
 
3
 
 assay system
(Amersham Pharmacia Biotech).
 
Evaluation of IP
 
3
 
R Activity.
 
Cells were attached to poly-
 
L
 
-
lysine and collagen-coated coverslips, and loaded with either 20
 
 
 
M Furapta-AM for 60 min in a physiological salt solution (in
mM): 150 NaCl; 4 KCl; 2 CaCl
 
2
 
; 1 MgCl
 
2
 
, 5 Hepes; and 5.6
glucose adjusted to pH 7.4 with NaOH. The Furapta-loaded cells
were then permeabilized by incubation with 40 
 
 
 
M 
 
 
 
-escin for
2–4 min in an internal solution to wash out Furapta in the cyto-
plasm, which enabled measurement of the Ca
 
2
 
 
 
 concentration
within the organelles (27). The ratio of fluorescence intensities by
excitations at 340 and 380 nm of 30–40 cells within a frame was
normalized so that 1 and 0 corresponded, respectively, to the val-
ues just before the application of IP
 
3
 
 and after complete depletion
by 10 
 
 
 
M at 300 nM Ca
 
2
 
 
 
. The initial 20 s period for the nor-
malized time course was fitted by single exponential function, e
 
-rt
 
.
The rate constant, r (s
 
 
 
1
 
), thus estimated was used as an index of
the IP
 
3
 
 receptor activity.
 
Electrophysiology.
 
For electrophysiological measurements,
coverslips plated with DT40 cells were transferred to the record-
ing chamber, or DT40 cells grown in suspension were collected,
resuspended in standard external, modified Ringer’s solution (in
mM: NaCl 145; KCl 2.8; CsCl 10; MgCl
 
2
 
 2; CaCl
 
2
 
 10; glucose
10; and Hepes 5, adjusted to pH 7.2 with NaOH), and allowed to
settle in the recording chamber for 5 min. The standard pipette-
filling solution contained (in mM): CsOH 145; glutamate 145;
NaCl 8; MgCl
 
2
 
 1; EGTA 10; Mg
 
2
 
ATP 2; GTP 0.2; Hepes 5, ad-
justed to pH 7.2 with CsOH. To avoid spontaneous activation of
HSOC currents, [Ca
 
2
 
 
 
]
 
i
 
 in the pipette solution was clamped to
 
 
 
100 nM by supplement with a mixture of 10 mM Cs-BAPTA
and 4.3 mM CaCl
 
2
 
. Pipette resistance ranged from 2 to 4 M
 
 
 
when filled with the pipette solution. Patch pipettes were made
from borosilicate glass capillaries (KIMAX-51; Kimble Products)
using a model P-87 Flaming-Brown micropipette puller (Sutter
Instrument). Patch-clamp experiments were performed in the
tight-seal whole-cell configuration at 21–25
 
 
 
C. High-resolution
current recordings were acquired by a computer-based patch-
clamp amplifier system (EPC-9; HEKA). Immediately following
establishment of the whole-cell configuration, 50 ms voltage
ramps spanning the voltage range of –150–
 
 
 
50 mV were deliv-
ered from a holding potential of 0 mV at a rate of 0.5 Hz over a
period of 200 s. All voltages were corrected for a liquid junction
potential of 10 mV between external and internal solutions. Cur-
rents were filtered at 2.3 kHz and digitized at 100 
 
 
 
s intervals.
Capacitative currents and series resistance were determined and
corrected before each voltage ramp using the automatic capaci-
tance compensation of the EPC-9. For analysis, the very first
ramps before activation of SOC currents (usually 1–3) were digi-
tally filtered at 2 kHz, pooled and used for leak-subtraction of all
subsequent current records. The low-resolution temporal devel-
opment of inward currents was extracted from the leak-corrected
individual ramp current records by measuring the current ampli-
tude at 
 
 
 
130 mV.
 
NF-AT Activity.
 
NF-AT activity was quantitated with Lu-
mat LB 9501 (Berthold Japan) using the NF-AT luciferase gene
and the Dual-Luciferase™ Assay System (Promega) as described
in Sugawara et al. (29). Luciferase activity was determined in trip-
licate for each experimental condition.
 
Online Supplemental Materials.
 
Supplemental figures can be
accessed at http://www.jem.org/cgi/content/full/195/6/673/
DC1. The data section includes the Northern blot analysis of RNA
expression of TRP isoforms and measurements of TG-induced
CCE in the high K
 
 
 
 depolarizing solution in DT40 cells.
 
Results
 
Targeted Disruption of the TRP1 Gene.
 
In agreement
with previous reports that a 
 
trp1
 
 transcript is detected in
various human tissues including spleen, we found that the
 
trp1
 
 transcript was expressed in mouse spleen cells as well as
chicken DT40 B cells (data not shown and Fig. 1 E).
Herein, we took a genetic approach to study the physio-
logical role of TRP1 in B cells. The 
 
trp1
 
 gene locus in
DT40 cells was disrupted by homologous recombination
(26). The targeting vectors carry a neomycin or histidinol
resistance gene cassette replacing the chicken genomic se-
quence, which contains the exon corresponding to the
transmembrane region H5 of TRP1 (30) (Fig. 1 A–C).
Southern and Northern blot analysis confirmed disruption
of 
 
trp1
 
 gene (Fig. 1 D and E), and confocal immunoimages
demonstrated loss of TRP1 proteins in mutant cells (Fig. 1
F). The level of cell surface expression of BCR examined
by staining with FITC-conjugated anti-chicken IgM anti-
body on TRP1-deficient clones was indistinguishable from
that of parental DT40 cells (Fig. 1 G).
 
Defects of BCR-mediated Ca
 
2
 
 
 
 Mobilization in TRP1-defi-
cient B Cells.
 
We used digital video fluorescence imaging
of the Ca
 
2
 
 
 
-sensitive dye Fura-2 to compare BCR-induced
[Ca2 ]i changes in single WT and TRP1-deficient DT40 B
cells. In the presence of 2 mM extracellular Ca2 , we ob-
served the averaged [Ca2 ]i increase from  70 to 250 nM
in WT cells, whereas this [Ca2 ]i increase was significantly
reduced in TRP1-deficient cells (Fig. 2 A), demonstrating
that TRP1 participates in BCR-mediated Ca2  mobiliza-
tion. To examine whether this Ca2  defect in TRP1-defi-
cient cells is solely attributable to insufficient Ca2  influx,
we also assessed the averaged [Ca2 ]i rise in the absence of676 Control of BCR-induced Ca2  Signal by TRP1
extracellular Ca2 . As shown in Fig. 2 B, a transient release
from intracellular Ca2  pools was also affected by loss of
TRP1. Since the augmentation of [Ca2 ]i rises by addition
of external Ca2  to solution, a hallmark of Ca2  influx, was
significantly potentiated in WT in comparison to that in
mutant cells (Fig. 2 C), we conclude that TRP1 partici-
pates in both Ca2  release and Ca2  influx upon BCR
cross-linking. In support of this conclusion, the defects in
TRP1 -14 cells were restored by reintroduction of human
TRP1 cDNA (Fig. 2 A–C).
Ca2  Release Defect in TRP1-deficient B Cells. Given
the evidence that BCR utilizes IP3 to release Ca2  from the
ER stores through its binding to P3Rs (31), the compro-
mised Ca2  release in TRP1-deficient cells could be ex-
plained by the defect in IP3 generation and/or by that in
IP3R function. The former possibility is unlikely, because
both levels and kinetics of IP3 generation after BCR cross-
linking were comparable in mutant and WT DT40 B cells
(Fig. 3 A). Then, to examine the latter possibility, we di-
rectly assessed the function of IP3Rs by monitoring the
Ca2  concentration in the lumen of the Ca2  stores (lumi-
nal Ca2  monitoring system) (Fig. 3 C–E; reference 27)
and studying the dose–response behavior of IP3-mediated
Ca2  release in WT and TRP1-deficient cells. As shown in
Fig. 3 E, TRP1-deficient cells manifested significantly
lower IP3 sensitivity compared with WT DT40 cells, sug-
gesting that the diminished activity of IP3Rs per se could at
least partly account for the observed attenuation of Ca2 
release in TRP1-deficient B cells. Furthermore, since the
expression levels of IP3R-1 and IP3R-2 were indistinguish-
able in WT and mutant cells (Fig. 3 B), it is likely that re-
duced activity of a normal number of IP3Rs is responsible
for the observed decrease in Ca2  release rates.
Ca2  Influx Defect in TRP1-deficient B Cells. To test the
hypothesis that TRP1 is part of the SOCs in B cells, we
stimulated WT and TRP1-deficient DT40 B cells with
thapsigargin (TG), an inhibitor of SERCA Ca2 -ATPases,
that depletes intracellular Ca2  stores and elicits CCE. As
shown in Fig. 4 A, in the absence of extracellular Ca2 , TG
caused a transient Ca2  rise in both WT and mutant cells,
indicating that TG-sensitive Ca2  stores are not affected by
loss of TRP1. Readmission of extracellular Ca2  led to a
steep increase of [Ca2 ]i in WT B cells, whereas the [Ca2 ]i
increase was attenuated by  50% in TRP1-deficient DT40
B cells, demonstrating an important role of TRP1 in in-
ducing CCE. Ca2  influx through plasma membrane Ca2 
channels is driven by the electrochemical gradient across
the plasma membrane. To exclude the possibility that the
observed inhibition of Ca2  influx in TRP1-deficient cells
is due to decrease in electrical driving force for Ca2  via
membrane depolarization by TG treatment, we compared
CCE in WT and TRP1-deficient DT40 cells in the pres-
ence of K  ionophore valinomycin (2  M) and 8 mM ex-
tracellular K , previously reported to maintain the cell
membrane potential at  –75 mV (32). Under this condi-
tion, CCE in mutant cells was still significantly less than
that in WT cells (Fig. 4 B). Likewise, when high K  (30
mM)-containing solution was employed to establish depo-
larizing experimental conditions, TRP1-deficient cells ex-
hibited a reduced CCE component compared with WT
cells (Fig. 4 B). Since independent TRP1-deficient clones,
TRP1 -14 and TRP1 -16, showed virtually identical re-
sponses, data for the two clones were combined below.
To formally demonstrate that the Ca2  influx defect by
loss of TRP1 is due to loss of SOC function, we directly
compared SOC currents in WT and TRP1-deficient
Figure 1. Targeted disruption of the TRP1 gene in DT40 B lympho-
cytes. Partial restriction map of chicken TRP1 gene (A), targeting con-
struct (B), and expected structure of the disrupted allele (C). (D) Southern
blot analysis of genomic DNAs from DT40 cells. Genomic DNAs were
prepared from WT ( / ),  neo-targeted ( / ), and neo/his-targeted
( / ) clones, digested with XbaI, and hybridized with a 3 -flanking
probe. The restriction endonuclease cleavage site of XbaI is abbreviated as
X. (E) Northern blot analysis of WT and TRP1-deficient DT40 cells
(clone TRP1 -14). (F) Immunolocalization of TRP1 in WT cells, and
loss of its expression in TRP1 -14 cells. The fluorescence images were
acquired with a confocal laser microscope. (G) BCR expression on
TRP1-deficient DT40 cells. DT40 cells were stained with FITC-conju-
gated anti–chicken IgM Ab.677 Mori et al.
DT40 cells in whole-cell patch clamp recordings. In the
vast majority of WT DT40 cells (27 out of 30), intracellular
dialysis with 10  M IP3 via the patch pipette elicited in-
ward currents that showed the salient features of CRAC
currents (6): a positive reversal potential of  50 mV and
inward rectification over the voltage range from –150–50
mV (Fig. 4 C; 200 s). The number of cells with detectable
SOC currents was clearly reduced in TRP1-deficient cells
in that only 6 out of 29 mutant cells showed detectable
SOC currents (Fig. 4 D). Although SOCs could not be de-
tected in  80% of mutant cells, the remaining  20% of
mutant cells manifested similar characteristics in both peak
current density and half-maximal activation time of SOC
currents ( 1.98   0.35 pA/pF and 42.1   14.7 s; n   6)
to those in WT cells ( 1.88   0.19 pA/pF and 43.0   6.3 s;
n   27) (Fig. 4 D). In mutant and WT cells, the SOC
currents showed similar shape of I-V curve (Fig. 4 C, left
panel). Moreover, resistance to time-dependent inactiva-
tion of the SOC currents was also similar between mutant
and WT cells (Fig. 4 C, right panel): 500 s after establish-
ment of whole-cell configuration, current amplitudes re-
mained 100   7 and 98   6% of the peak currents for WT
(n   5) and mutant cells (n   4), respectively. These simi-
larities could not be ascribed to contaminated WT cells in
the TRP1-deficient preparation, because WT alleles could
not be detected even though by using the PCR analysis
(Fig. 4 E). Thus, genetic elimination of TRP1 impaired
expression of functional SOCs activated by IP3-dependent
Ca2  release from ER stores.
Ca2  Oscillation Defects in TRP1-Deficient B Cells. Ca2 
signals often take the form of oscillations, i.e., periodic
spiking of [Ca2 ]i. Recent reports suggest that characteris-
tics of Ca2  oscillation, such as amplitude and frequency,
contribute to the efficacy and specificity of signaling (5,
33). In WT cells and in the presence of external Ca2 ,
BCR stimulation evoked an initial Ca2  transient peaking
at  35 s (Fig. 5 B), which was followed by Ca2  oscilla-
tions that lasted 30 min or longer (Fig. 5 A; reference 27).
By contrast, and similar to responses observed in WT
DT40 cells after omission of external Ca2 , the BCR-
Figure 2. Disruption of TRP1 gene atten-
uates BCR-induced Ca2  mobilization in
DT40 cells. Average time courses of Ca2 
responses evoked in the presence (A, 2 mM
Ca2 ) and absence (B, EGTA) of extracellu-
lar Ca2  upon BCR stimulation with anti-
BCR antibody M4 (1  g/ml) in WT cells
(white box), in a TRP1-deficient clone
TRP1 -14 (black box), and in TRP1 -14
cells expressing recombinant hTRP1
(TRP1/14, black triangle). Anti-BCR anti-
body was applied as indicated by the hori-
zontal bars above the traces. (C) Peak
BCR-induced [Ca2 ]i rises in WT (n   
75), in two independent TRP1-deficient
clones, TRP1 -14 (n   31) and TRP1 -16
(n   39), and in TRP1 -14 cells expressing recombinant hTRP1 (TRP1/14)(n   22). The responses of the two independent TRP1-deficient clones
were indistinguishable. Data points and columns are the mean  SE. *P   0.05; **P   0.01; ***P   0.001. P values are the results of Student’s t test.
Figure 3. IP3-induced Ca2  release is suppressed in TRP1-deficient
cells. (A) Intact BCR-induced IP3 production in TRP1-deficient cells.
Cells were stimulated with anti-BCR antibody M4 (1  g/ml) for the in-
dicated time. Data points are the mean  SE from four experiments. (B)
Western blot analysis demonstrating the IP3R-1 or IP3R-2 expression in-
distinguishable in WT and mutant cells using a polyclonal antibody against
either IP3R-1 or IP3R-2. (C) The ER luminal Ca2  concentration in-
creased with activation of the Ca2  pump, and declined upon application
of IP3. (D) The level of activation of the IP3R can be quantitatively com-
pared by the initial rate of Ca2  release, which we estimated by fitting an
exponential curve (continuous line) to the initial part of the Ca2  decay
signal (black circles). (E) IP3-concentration dependence of Ca2  release.
Release rates were obtained by fitting a single exponential to the initial
part of Ca2  decay signal measured in luminal Ca2  monitoring (reference
27). The continuous curve and dotted curve represent the best fit hyper-
bolic equations, rmax/(1   EC50/[IP3]), where rmax is the extrapolated val-
ues of the maximal rate of Ca2  release, for Ca2  release rates in WT and
TRP1-deficient cells, respectively. rmax and EC50 were 0.153 s-1 and 0.66
 M in WT cells, and 0.118 s 1 and 0.83  M in mutant cells. Data ob-
tained from TRP1 -14 and TRP1 -16 were combined. Data points are
the mean  SE from six to seven experiments. **P   0.01.678 Control of BCR-induced Ca2  Signal by TRP1
induced Ca2  response in TRP1-deficient cells showed
significant delay to reach first peak and reduced number of
oscillation (Fig. 5 A–C). Strikingly, the number of oscilla-
tions in mutant cells exhibited further reduction by omis-
sion of external Ca2 , again confirming that the TRP1 def-
icit leads to attenuation of Ca2  release activity through
IP3R. Collectively, TRP1 plays an important role in nor-
mal BCR-mediated Ca2  oscillations by regulating both
Ca2  release and Ca2  influx.
DT40 B cells lacking TRP1 have allowed us to directly
assess the effects of modulation of BCR-mediated Ca2  os-
cillations on NF-AT activity. As shown in Fig. 5 D, NF-AT
activation was reduced in the mutant cells. Thus, the result
suggests that delayed Ca2  onset and/or reduced number of
Ca2  oscillations, mediated by loss of TRP1, have an im-
portant impact on transcriptional regulation in B cells.
Discussion
We have demonstrated that TRP1 is critical for regula-
tion of both IP3R Ca2  release channels and SOCs in
DT40 B lymphocytes. The functional impairment of these
channels resulted in a decrease of the BCR-mediated Ca2 
mobilization, thereby leading to a reduction of NF-AT ac-
tivity. Therefore, we have obtained the direct evidence
that TRP1 indeed functions in the BCR signaling context,
which in turn modulates gene expression in B cells.
Our data indicate that disruption of the trp1 gene signifi-
cantly but incompletely eliminates SOC activity in mutant
cells, which could be accounted for by at least two possibil-
ities. First, this may imply the existence of multiple SOC
subtypes in B lymphocytes. Because there are  20 mem-
bers of the TRP family proteins including seven close
mammalian relatives of the Drosophila trp gene (34), other
members of these TRP family proteins could be responsi-
ble for the residual SOC activity in a TRP1-independent
manner. Second, TRP proteins may assemble into a het-
eromultimeric complex comprising TRP1, where channel
characteristics are determined by subunit compositions
(35). In this regard, TRP1 could function as a regulatory
subunit rather than as an indispensable subunit for the SOC
activity. Although our data could not definitely distinguish
these two possibilities, we speculate that the first possibility
is more likely. Assuming that TRP1 could be a regulatory
subunit of the SOCs in WT cells, one could envision that
characteristics of SOC currents would significantly differ
between WT and TRP1-deficient cells. However, our
electrophysiological analysis demonstrated that despite
Figure 4. CCE is impaired in
TRP1-deficient cells. TG-induced
Ca2  release and CCE. (A and B)
(A) Time course of Ca2  responses
induced by external perfusion of 2
 M TG, that passively depletes in-
ternal Ca2  stores in the Ca2 -free
solution containing EGTA, and by
subsequent addition of 2 mM extra-
cellular Ca2  to evoke CCE, in WT
(white box), TRP1 -14 (black box),
and hTRP1-expressing TRP1 -14
cells (TRP1/14, white triangle).
The solutions contained 4 mM K .
(B) Peak [Ca2 ]i rises attributable to
Ca2  release and entry induced by TG
in WT, mutant clones, TRP1 -14
and TRP1 -16, and hTRP1-express-
ing TRP1 -14 cells (TRP1/14).
Experiments were performed in the
4 mM K -containing, physiological
salt solution (n   114, 65, 55, and
35 for WT, TRP1 -14, TRP1 -16,
and TRP1/14, respectively), in high
K  (30 mM) solution (n   153, 106,
and 86 for WT, TRP1 -14, and
TRP1 -16, respectively), and in 8 mM K  plus 2  M valinomycin-containing solution (n   36 and 19 for WT and TRP1 -14, respectively). The re-
sponses of the two independent TRP1-deficient clones were indistinguishable. Data points and columns are the mean  SE. **P   0.01; ***P   0.001.
SOC currents induced by internal dialysis with 10  M IP3 in DT40 cells (C and D). (C, left) Representative, high resolution current records at 10 s (top
trace) and 200 s (lower trace) after whole cell break-in, subtracted with pooled leak currents (see Materials and Methods). The voltage ramp protocol is
schematically shown on top. (Right) Average time courses of ionic currents evoked by 10  M IP3 at –130 mV (indicated by an arrow in C in SOC-pos-
itive WT cells. Average time courses in TRP1-deficient cells were similar to WT cells. Spontaneous activation of SOC currents was not observed in the
absence of intrapipette IP3, since [Ca2 ]i in the pipette solution was clamped to  100 nM (see Materials and Methods). Data are mean  SE. The whole-
cell configuration of patch clamp recording is established at the time 0. (D) Number of WT and TRP1-deficient cells developing SOC currents in re-
sponse to intracellular perfusion of 10  M IP3. Only 20% of mutant cells show SOC current activation, while 90% of WT cells develops SOC current.
(E) PCR analysis of genomic DNA demonstrating the TRP1-deficient preparations free from contamination of WT cells. PCR primers were designed as
described in Materials and Methods to amplify the  2,080-bp genomic fragment in WT cells but not in mutant cells. Addition of 1/100 amount of ge-
nomic DNA from WT cells to that from the mutant line leads to clear PCR amplification of the WT  2,080-bp band, revealing that contamination of
WT cells was  1% of the cell population, if at all.679 Mori et al.
nondetectable SOC currents in  80% of the mutant cells,
the remaining  20% had SOC currents with characteristics
that were indistinguishable from WT cells. Considering
that a gene knock-out approach sometimes causes upregu-
lation of other functionally redundant molecules in an at-
tempt to cope with the deficit, this compensation extent
may vary for each TRP1-deficient cell. In this regard, it has
been demonstrated that activation of CRAC channel by
IP3 appears to be of all-or-none type regulation (36), sug-
gesting that opening of CRAC channels might be medi-
ated by the small changes of key component(s). If so in the
case of DT40 cells, apparently normal SOCs in  20% of
TRP1-deficient cells may be accounted for by sufficient
compensation that enables SOCs to cross the threshold for
all-or-none activation.
In [Ca2 ]i measurements using high K -containing ex-
ternal solution, which limits Ca2  entry only through
Ca2 -selective channels such as CRAC channels, majority
of WT cells ( 80%) displayed sustained TG-induced
[Ca2 ]i responses upon readmission of external Ca2 ,
whereas this sustained TG-induced [Ca2 ]i responses were
observed only in minority of mutant cells ( 10%) (Fig.
S2). These results appear to be consistent with the electro-
physiological recording data that the CRAC-like SOC
current was detectable in  20% of mutant cells. However,
in the TG-induced [Ca2 ]i response, the remaining 90% of
mutant cells still manifested a small transient or slowly ris-
ing tiny Ca2  response. The straightforward explanation for
why this transient rapid component detected by Ca2 
imagining might have escaped detection by patch clamp is
that TG-mediated response could be composed of two
components: IP3R-mediated component and other IP3R-
independent one. IP3 used in electrophysiology should ac-
tivate the SOC coupled to IP3R-mediated Ca2  release
from the internal Ca2  store ER, while TG, that passively
depletes internal stores by blockade of ER Ca2 -ATPase in
Ca2  imaging, may activate the SOC coupled to IP3R as
well as SOCs coupled to ryanodine receptors (37). In ac-
cordance with this, Parekh et al. indeed reported that IP3
and TG are not equivalent in potency for activation of the
CRAC current in rat basophilic leukemia cells (RBL-1) in
electrophysiological recordings (36). It is thus possible that
multiple SOC subtypes and/or multiple SOC activation
mechanisms, which respond somewhat differently to store
depletion signals, are expressed in DT40 cells.
Since TRP1, but not IP3R, is a plasma membrane–resi-
dent protein, our results that deletion of TRP1 perturbed
the function of IP3Rs were somewhat surprising. How-
ever, given the previous observations that TRP3 directly
binds to IP3Rs (37–41) and that the functional IP3R-bind-
ing sequence identified in TRP3 is conserved in TRP1 and
other TRP proteins (42), it is reasonable to anticipate that
TRP1, like TRP3, directly interacts with IP3Rs. If so, the
straightforward explanation for our data is that the physical
interaction between TRP1 and IP3Rs is required for opti-
mal activation of both IP3Rs and SOCs. Hence, we pro-
pose that TRP1 functions not only as one component of
SOCs but also as a positive regulator of IP3Rs in B cells,
thereby contributing to the facilatory communication be-
tween the plasma membrane and ER. This facilitation of
the coupling between the IP3Rs and SOCs by TRP1 in B
cells promotes the coordinated aspect of Ca2  signaling,
Ca2  oscillation, which could have significant impacts on
the efficiency and specificity of gene expression (5, 33).
Our present view concerning the role of TRP–IP3R inter-
action seemingly contradicts the apparently normal CCE
induced by TG in DT40 cells lacking all three IP3R types
Figure 5. Reduced Ca2  oscillation and NF-AT activity in TRP1-
deficient cells. (A) Representative Ca2  responses upon BCR ligation in
Ca2 -containing and Ca2 -free external solution in single WT and mu-
tant DT40 cells. Anti-BCR antibody was applied as indicated by the hor-
izontal bars above the traces. (B) Delay of Ca2  response to reach initial
peak after application of anti-BCR antibody. n   90 and 88 for WT and
TRP1 , respectively, in Ca2 -containing solution, and n   46 and 53 for
WT and TRP1 , respectively, in Ca2 -free external solution. (C) Num-
ber of Ca2  oscillations within 60 min of BCR stimulation. n   90 and
150 for WT and TRP1 , respectively, in Ca2 -containing solution, and
n   89 and 139 for WT and TRP1 , respectively, in Ca2 -free external
solution. (D) NF-AT activity in WT and mutant cells. Cells transfected
with the NF-AT luciferase gene were analyzed as described in Materials
and Methods. The experiment shown is representative of three indepen-
dent trials. Data points and columns are the mean  SE. **P   0.01;
***P   0.001.680 Control of BCR-induced Ca2  Signal by TRP1
(29). However, given the evidence that the ryanodine re-
ceptors RyR1 and RyR3 gates SOCs independently of
IP3Rs in DT40 cells, one possibility is that the persistence
of SOC is due to RyRs in the triple IP3R-deficient cells
(43). Alternatively, yet unidentified Ca2  release pathways
may be involved in the induction of CCE in DT40 cells.
In the case of the Drosophila photoreceptor, phospholi-
pase C (PLC)-  is associated with TRP through mutual in-
teraction with a scaffolding protein, thereby making a
spatially compact signaling complex between rhodopsin,
PLC- , TRP, and other regulatory proteins (44). This
spatial compartmentation is thought to be important for ef-
ficient operation of the light-induced Ca2  signaling in
photoreceptor cells (45). In the case of BCR signaling,
PLC- 2, instead of PLC- , is used to generate IP3. Given
the evidence that PLC- 2 should be targeted to subdo-
mains of the plasma membrane known as rafts for generat-
ing IP3  (46), the compact signaling complex including
PLC- 2, TRP1, and IP3R, in close analogy to the Drosoph-
ila photoreceptor, is likely formed in rafts after BCR liga-
tion. Indeed, TRP1 is known to be concentrated in rafts
(47), wherein TRP1, with coordination of candidate scaf-
folding proteins such as a INAD (44) homologue or possi-
bly SNAP-25 (48), might contribute to assembling the
CCE signaling complex. Hence, TRP1 deficit may perturb
an assembly of this signaling complex to decrease local con-
centration of functional SOCs.
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